| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.25 | 5e-11 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-11 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.07 |